Complications of Hepatic Chemoembolization

 

 Buy Article Permissions and Reprints

ABSTRACT

Transarterial hepatic chemoembolization continues to evolve as an integral therapy for unresectable primary and secondary liver tumors. Despite relatively low morbidity, major complications may be seen. This article provides an overview of the spectrum of vascular and nonvascular complications related to this therapy.

REFERENCES

• 1 Hong K, Liapi E, Georgiades C S, Geschwind J F. Case-controlled comparison of a percutaneous collagen arteriotomy closure device versus manual compression after liver chemoembolization.  J Vasc Interv Radiol. 2005;  16 339-345
  PubMedGoogle Scholar
• 2 Yoon D Y, Park J H, Chung J W, Han J K, Han M C. Iatrogenic dissection of the celiac artery and its branches during transcatheter arterial embolization for hepatocellular carcinoma: outcome in 40 patients.  Cardiovasc Intervent Radiol. 1995;  18 16-19
  PubMedGoogle Scholar
• 3 Covey A M, Brody L A, Maluccio M A, Getrajdman G I, Brown K T. Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients.  Radiology. 2002;  224 542-547
  CrossrefPubMedGoogle Scholar
• 4 Inaba Y, Arai Y, Matsueda K, Takeuchi Y, Aramaki T. Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy.  J Vasc Interv Radiol. 2001;  12 957-963
  PubMedGoogle Scholar
• 5 Nakamura H, Hashimoto T, Oi H, Sawada S, Furui S. Prevention of gastric complications in hepatic arterial chemoembolization. Balloon catheter occlusion technique.  Acta Radiol. 1991;  32 81-82
  PubMedGoogle Scholar
• 6 Hirakawa M, Iida M, Aoyagi K, Matsui T, Akagi K, Fujishima M. Gastroduodenal lesions after transcatheter arterial chemo-embolization in patients with hepatocellular carcinoma.  Am J Gastroenterol. 1988;  83 837-840
  PubMedGoogle Scholar
• 7 Leung D A, Goin J E, Sickles C, Raskay B J, Soulen M C. Determinants of postembolization syndrome after hepatic chemoembolization.  J Vasc Interv Radiol. 2001;  12 321-326
  CrossrefPubMedGoogle Scholar
• 8 Kuroda C, Iwasaki M, Tanaka T et al.. Gallbladder infarction following hepatic transcatheter arterial embolization. Angiographic study.  Radiology. 1983;  149 85-89
  PubMedGoogle Scholar
• 9 Chung J W, Park J H, Han J K, Choi B I, Kim T K, Han M C. Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role.  J Vasc Interv Radiol. 1998;  9 495-500
  PubMedGoogle Scholar
• 10 Arora R, Soulen M C, Haskal Z J. Cutaneous complications of hepatic chemoembolization via extrahepatic collaterals.  J Vasc Interv Radiol. 1999;  10 1351-1356
  PubMedGoogle Scholar
• 11 Yamaura K, Higashi M, Akiyoshi K, Itonaga Y, Inoue H, Takahashi S. Pulmonary lipiodol embolism during transcatheter arterial chemoembolization for hepatoblastoma under general anaesthesia.  Eur J Anaesthesiol. 2000;  17 704-708
  CrossrefPubMedGoogle Scholar
• 12 Kwok P C, Lam T W, Lam C L, Lai A K, Lo H Y, Chan S C. Rare pulmonary complications after transarterial chemoembolisation for hepatocellular carcinoma: two case reports.  Hong Kong Med J. 2003;  9 457-460
  PubMedGoogle Scholar
• 13 Chung J W, Park J H, Im J G, Han J K, Han M C. Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma.  Radiology. 1993;  187 689-693
  CrossrefPubMedGoogle Scholar
• 14 Tajima T, Honda H, Kuroiwa T et al.. Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer.  J Vasc Interv Radiol. 2002;  13 893-900
  PubMedGoogle Scholar
• 15 Brown K T. Fatal pulmonary complications after arterial embolization with 40-120-micro m tris-acryl gelatin microspheres.  J Vasc Interv Radiol. 2004;  15 197-200
  CrossrefPubMedGoogle Scholar
• 16 Kessler J M, Harini A, Hong K, Georgiades C S, Geschwind J F. Toxicity of transcatheter arterial chemoembolization for unresectable liver tumors.  J Vasc Interv Radiol. 2005;  16 S54 (Abstract)
  PubMedGoogle Scholar
• 17 Civalleri D, Pellicci R, Decaro G et al.. Palliative chemoembolization of hepatocellular carcinoma with mitoxantrone, Lipiodol, and Gelfoam. A phase II study.  Anticancer Res. 1996;  16 937-941
  PubMedGoogle Scholar
• 18 Kobayashi S, Nakanuma Y, Terada T, Matsui O. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribiliary capillary plexus.  Am J Gastroenterol. 1993;  88 1410-1415
  PubMedGoogle Scholar
• 19 Kim W, Clark T W, Baum R A, Soulen M C. Risk factors for liver abscess formation after hepatic chemoembolization.  J Vasc Interv Radiol. 2001;  12 965-968
  CrossrefPubMedGoogle Scholar
• 20 Geschwind J F, Kaushik S, Ramsey D E, Choti M A, Fishman E K, Kobeiter H. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors.  J Vasc Interv Radiol. 2002;  13 1163-1166
  CrossrefPubMedGoogle Scholar
• 21 Patel S S, Tuite C M, Mondschein J I, Soulen M C. Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with prior biliary intervention.  J Vasc Interv Radiol. 2005;  16 S54 (Abstract)
  PubMedGoogle Scholar
• 22 Pitt H A, Zuidema G D. Factors influencing mortality in the treatment of pyogenic hepatic abscess.  Surg Gynecol Obstet. 1975;  140 228-234
  PubMedGoogle Scholar
• 23 Pitt H A. Surgical management of hepatic abscesses.  World J Surg. 1990;  14 498-504
  CrossrefPubMedGoogle Scholar
• 24 Reed R A, Teitelbaum G P, Daniels J R, Pentecost M J, Katz M D. Prevalence of infection following hepatic chemoembolization with cross-linked collagen with administration of prophylactic antibiotics.  J Vasc Interv Radiol. 1994;  5 367-371
  CrossrefPubMedGoogle Scholar
• 25 Tarazov P G, Polysalov V N, Prozorovskij K V, Grishchenkova I V, Rozengauz E V. Ischemic complications of transcatheter arterial chemoembolization in liver malignancies.  Acta Radiol. 2000;  41 156-160
  CrossrefPubMedGoogle Scholar
• 26 Cubiella J, Sans M, Llovet J M et al.. Pulmonary abscess as a complication of transarterial embolization of multinodular hepatocellular carcinoma.  Am J Gastroenterol. 1997;  92 1942-1943
  PubMedGoogle Scholar
• 27 Wong E, Khardori N, Carrasco C H, Wallace S, Patt Y, Bodey G P. Infectious complications of hepatic artery catheterization procedures in patients with cancer.  Rev Infect Dis. 1991;  13 583-586
  PubMedGoogle Scholar
• 28 Yokoi Y, Suzuki S, Sakaguchi T et al.. Subphrenic abscess formation following superselective transcatheter chemoembolization for hepatocellular carcinoma.  Radiat Med. 2002;  20 45-49
  PubMedGoogle Scholar
• 29 Kono N, Nakanuma Y. Ultrastructural and immunohistochemical studies of the intrahepatic peribiliary capillary plexus in normal livers and extrahepatic biliary obstruction in human beings.  Hepatology. 1992;  15 411-418
  PubMedGoogle Scholar
• 30 Berger D H, Carrasco C H, Hohn D C, Curley S A. Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications.  J Surg Oncol. 1995;  60 116-121
  PubMedGoogle Scholar
• 31 Huang Y S, Chiang J H, Wu J C, Chang F Y, Lee S D. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test.  Am J Gastroenterol. 2002;  97 1223-1227
  CrossrefPubMedGoogle Scholar
• 32 Chung J W, Park J H, Han J K et al.. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.  Radiology. 1996;  198 33-40
  CrossrefPubMedGoogle Scholar
• 33 Pentecost M J, Daniels J R, Teitelbaum G P, Stanley P. Hepatic chemoembolization: safety with portal vein thrombosis.  J Vasc Interv Radiol. 1993;  4 347-351
  PubMedGoogle Scholar
• 34 Spahr L, Becker C, Pugin J, Majno P E, Hadengue A. Acute portal hemodynamics and cytokine changes following selective transarterial chemoembolization in patients with cirrhosis and hepatocellular carcinoma.  Med Sci Monit. 2003;  9 CR383-CR388
  PubMedGoogle Scholar
• 35 Sato M, Yamada R, Uchida B, Hedgepeth P, Rosch J. Effects of hepatic artery embolization with Lipiodol and gelatin sponge particles on normal swine liver.  Cardiovasc Intervent Radiol. 1993;  16 348-354
  PubMedGoogle Scholar
• 36 Sakamoto I, Aso N, Nagaoki K et al.. Complications associated with transcatheter arterial embolization for hepatic tumors.  Radiographics. 1998;  18 605-619
  CrossrefPubMedGoogle Scholar
• 37 Huo T I, Wu J C, Lee P C, Chang F Y, Lee S D. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.  Liver Int. 2004;  24 210-215
  CrossrefPubMedGoogle Scholar
• 38 Kim M J, Lee S W, Kim G A, Song J H. Acute renal failure after transarterial chemoembolization progressing to chronic renal failure in hepatocellular carcinoma.  Nephrol Dial Transplant. 2000;  15 741-742
  PubMedGoogle Scholar
• 39 Balestrero L M, Beaver C R, Rigas J R. Hypertensive crisis following meperidine administration and chemoembolization of a carcinoid tumor.  Arch Intern Med. 2000;  160 2394-2395
  CrossrefPubMedGoogle Scholar

Timothy W.I ClarkM.D. 

Chief, Section of Vascular and Interventional Radiology, New York University Medical Center

Suite HE-221, 560 First Avenue, New York, NY 10016